Bicara Property Plant And Equipment Net from 2010 to 2024

BCAX Stock   20.79  0.17  0.81%   
Bicara Therapeutics Property Plant And Equipment Net yearly trend continues to be fairly stable with very little volatility. Property Plant And Equipment Net will likely drop to about 798 K in 2024. Property Plant And Equipment Net is the total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects Bicara Therapeutics' investment in assets used for production. View All Fundamentals
 
Property Plant And Equipment Net  
First Reported
2010-12-31
Previous Quarter
815 K
Current Value
798 K
Quarterly Volatility
60.1 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Bicara Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bicara Therapeutics' main balance sheet or income statement drivers, such as Tax Provision of 3.3 K, Net Interest Income of 663.3 K or Interest Income of 724.9 K, as well as many indicators such as . Bicara financial statements analysis is a perfect complement when working with Bicara Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Bicara Therapeutics Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Bicara Stock Analysis

When running Bicara Therapeutics' price analysis, check to measure Bicara Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bicara Therapeutics is operating at the current time. Most of Bicara Therapeutics' value examination focuses on studying past and present price action to predict the probability of Bicara Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bicara Therapeutics' price. Additionally, you may evaluate how the addition of Bicara Therapeutics to your portfolios can decrease your overall portfolio volatility.